R&D >

Autologous Therapy

HOME > R&D > Autologous Therapy

Under construction please wait.
  • Develop and provide autologous anti-cancer therapy by using Bionanosome derived from cancer patient immune cell
  • Solve immunogenicity issues of the therapy
  • Service will begin with autologous Bionanosome + Doxorubicin in major domestic hospitals
  • Service will be expanded overseas by partnering and/or our affiliated companies